Log In
BCIQ
Print this Print this
 

ASP3291

  Manage Alerts
Collapse Summary General Information
Company Telsar Pharma Inc.
DescriptionMelanocortin (MC) receptor agonist
Molecular Target Melanocortin (MC) receptor
Mechanism of ActionMelanocortin 1 receptor (MC1R) agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat ulcerative colitis (UC)
Regulatory Designation
PartnerDrais Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/30/2012

Undisclosed

Undisclosed

0

Get a free BioCentury trial today